Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salbutamol and Ipratropium in pediatric acute asthma
NCT06918418Phase 4Completed
- Sponsor
- Children's Hospital and Institute of Child Health Multan
- Start
- Jan 2024
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of ipratropium bromide in asthma, sponsored by Children's Hospital and Institute of Child Health Multan. Primary endpoint: Pulmonary Asthma Score at 4 hours. Started Jan 2024; status: completed.
02
Drugs
ipratropium bromide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT06918418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06918418.